MCLAUGHLIN KEVIN F 4

4 · Vericel Corp · Filed May 1, 2026

AI-generated summary of this filing

Updated May 1, 2026

Vericel (VCEL) Director Kevin McLaughlin Receives 14,400 Shares

What Happened

Kevin F. McLaughlin, a director of Vericel Corporation (VCEL), acquired a total of 14,400 shares on April 29, 2026 through derivative conversion/exercise and the vesting of restricted stock units (RSUs). The transaction entries report $0 paid per share (awards/vested RSUs and derivative conversion), indicating these shares were received upon vesting/conversion rather than bought on the open market. This is an acquisition (not a sale) of company stock.

Key Details

Transaction date: April 29, 2026; Form 4 filed May 1, 2026 (timely within the Form 4 two-business-day window).
Reported transactions: exercise/conversion of derivative (code M) for 3,200 shares; grants/awards (code A) for 8,000 and 3,200 shares (total awards 11,200). Combined acquisitions reported = 14,400 shares at $0.00.
Shares owned after transaction: not disclosed in the provided summary of the filing.
Footnote highlights:
- F1–F3/F6: The shares came from RSUs (each RSU = one share). Some RSUs were granted April 30, 2025 and vest 100% on the earlier of April 30, 2026 (or the first annual meeting after April 30, 2025); other RSUs have a later vesting schedule noted in the filing.
- F5: An option referenced vests over a one-year period in equal monthly increments, contingent on continued service.
Transaction codes: M = exercise/conversion of derivative; A = award/grant (RSU vesting). Reported as derivative/award-related, not open-market purchase or sale.

Context

RSU vesting and derivative conversions are routine insider compensation events and do not necessarily indicate active buying or selling intent; these shares were issued/converted to the director upon vesting.
No immediate sale or cashless disposition of the newly acquired shares is indicated in the filing.

Form 4

Period: 2026-04-29

Director

Transactions

Exercise/Conversion
Common Stock
[F1]
2026-04-29+3,200→ 18,300 total
Exercise/Conversion
Restricted Stock Unit
[F2][F3][F4]
2026-04-29+3,200→ 0 total
→ Common Stock (3,200 underlying)
Award
Stock Option (Right to Buy)
[F5]
2026-04-29+8,000→ 8,000 total
Exercise: $33.43Exp: 2036-04-29→ Common Stock (8,000 underlying)
Award
Restricted Stock Unit
[F2][F6][F4]
2026-04-29+3,200→ 3,200 total
→ Common Stock (3,200 underlying)

Footnotes (6)

[F1]The shares of common stock were acquired by the Reporting Person as a result of the vesting of Restricted Stock Units (RSUs) granted to the Reporting Person on April 30, 2025.
[F2]Each RSU represents a contingent right to receive one share of common stock of Vericel Corporation.
[F3]These RSUs vest 100% on the earlier of April 30, 2026, or the date of the first Annual Meeting of Stockholders following April 30, 2025.
[F4]No expiration date for this type of award.
[F5]The option vests over a 1-year period, in equal monthly increments, contingent upon continued service to the Company.
[F6]These RSUs vest 100% on the earlier of April 29, 2027, or the date of the first Annual Meeting of Stockholders following April 29, 2026.

Signature

/s/ Sean Flynn, as Attorney-in-Fact for Kevin McLaughlin|2026-05-01

1 file